Fertility Test Market Size, Share, Trends, & Industry Analysis Report
By Product, By Mode of Purchase, By Application, By End User, and By Region – Market Forecast, 2025–2034
- Published Date: Oct-2025
- Pages: 125
- Format: PDF
- Report ID: PM2055
- Base Year: 2024
- Historical Data: 2020-2023
Overview
The fertility test market was valued at USD 7.14 billion in 2024 growing at a CAGR of 7.88% from 2025-2034. Growing rates of infertility fueled by lifestyle factors and late pregnancies along with increasing awareness regarding reproductive health and early diagnosis are driving growth in the market.
Key Insights
- Ovulation prediction kits led the market in 2024 as a result of increasing take-up of home-based fertility monitoring products.
- Hospitals and clinics projected to expand with highest CAGR, fueled by mounting need for clinical-grade tests and remote monitoring.
- North America dominated the market globally in 2024 owing to increasing infertility levels and high reproductive health awareness.
- The U.S. dominated North America in 2024 with high healthcare expenditure and advanced diagnostic infrastructure.
- Asia Pacific is projected to record the fastest growth, driven by increasing infertility prevalence and growing awareness of reproductive health.
- China dominated Asia Pacific due to increasing urban infertility and government efforts promoting reproductive healthcare accessibility.
Industry Dynamics
- Growing infertility due to lifestyle modifications and late pregnancy is fueling the need for fertility testing solutions.
- Surging awareness regarding reproductive wellness and early detection is increasing the adoption of home fertility tests
- High cost of testing and limited insurance reimbursement continue to be major hurdles in market growth
- Technological innovations in digital and AI-enabled fertility monitoring are developing new market prospects.
Market Statistics
- 2024 Market Size: USD 7.14 Billion
- 2034 Projected Market Size: USD 15.22 Billion
- CAGR (2025-2034): 7.88%
- North America: Largest Market Share
Fertility testing solutions provide individuals with insights into reproductive health, including ovulation tracking, hormone monitoring, and sperm analysis. Self-testing kits, laboratory tests, and digital platforms are integrated with mobile apps and data analytics to improve accuracy, convenience, and personalized health monitoring.
Increasing infertility resulting from changes in lifestyle and postponed pregnancies coupled with heightened awareness of reproductive health and early detection, are fueling demand for fertility testing across the world. The consumers are embracing in-home testing solutions for convenience, privacy, and timely health care.
Key players are introducing advanced, AI-based, and digital-integrated fertility testing solutions to improve accuracy, user experience and personalized suggestions. Growing e-commerce channels, collaboration with fertility clinics and developing markets are opening new growth prospects for manufacturers. The U.S. Census Bureau announced that retail e-commerce sales were USD 304.2 billion in Q2 2025. This is a 1.4% growth from the last quarter following seasonally adjusted figures.
Drivers & Opportunity
Rising infertility rates due to lifestyle changes and delayed pregnancies: Rising infertility due to lifestyle-related issues like stress, unhealthy diet, and postponement of childbearing is propelling demand for fertility test solutions. People are looking for timely information about reproductive health to conceive, resulting in greater adoption of home testing as well as clinical fertility tests. The World Health Organization (WHO) published that around 17.5% of the total adult population or roughly 1 out of every 6 individuals suffer from infertility in their lifetime.
Growing awareness regarding reproductive health and early diagnosis: Increasing public awareness of reproductive health and the advantages of early fertility evaluation is motivating customers to apply testing solutions. Awareness campaigns, healthcare guidance, and digital platforms are promoting proactive fertility monitoring and supporting market growth.
Segmental Insights
Product Analysis
Based on product, the segmentation includes ovulation prediction kits, fertility monitors, and male fertility testing products. The segment of ovulation prediction kits was the market leader in 2024 owing to widespread consumer interest in monitoring fertility at home. Additionally, the rise in awareness regarding precise tracking of ovulation and compatibility with mobile applications is further strengthening its use among reproductive-age women worldwide.
Male fertility testing products are expected to register the highest CAGR through the forecast period as a result of growing male infertility issues and enhanced availability of home-based sperm test kits. Furthermore, technology improvements are increasing test convenience and accuracy.
Mode of Purchase Analysis
Based on mode of purchase, the segmentation includes direct/prescription products, OTC products, and online products. The direct/prescription products segment of the market led in 2024 due to clinical reliability coupled with advice from healthcare providers. Additionally, these products are favored by patients for precise hormonal and fertility testing, facilitating steady revenue generation in developed markets.
The segment of online products is expected to expand at the highest CAGR attributed to increasing adoption of e-commerce and demand for discreet, home-delivered conception kits. Moreover, online channels make purchasing convenient, affordable, and easier to track digitally, which drives market growth.
Application Analysis
Based on application, the segmentation includes female fertility testing and male fertility testing. Female fertility testing dominated the industry in 2024 as a result of increasing demand for ovulation and hormonal evaluation solutions. For example, Valley Health opened a new fertility clinic in Winchester in October 2025 to offer extensive reproductive care. The center intends to extend high-level fertility solutions to more local patients. Additionally, growing awareness of early fertility testing and customized reproductive health planning remains market driving forces in the world.
The segment of male fertility testing is anticipated to expand at the highest CAGR owing to rising instances of male infertility as well as elevated awareness about the health of sperm. Furthermore, innovative at-home testing technologies and digital tracking are increasing consumer access.
End User Analysis
Based on end user, the segmentation includes home care settings, hospitals and fertility centers, and other end user. The home care settings market led the market in 2024 due to the growing desire among consumers for privacy and convenience during fertility testing. Furthermore, the integration with mobile applications and wearable devices raises usability, bolstering extended market penetration in urban areas.
Hospitals and fertility centers segment is expected to register the highest growth rate CAGR owing to the growing demand for clinical-grade fertility diagnostics. Moreover, alliances with diagnostic firms and integration of advanced lab-based testing solutions are also driving institutional adoption.
Regional Analysis
North America led the fertility test market with increasing cases of infertility and an increase in consciousness about reproductive health among women. Sexual and Reproductive Health Fund (SRHF) was initiated to enhance access to healthcare among under-served populations by investing USD 32.02 million in 2021. The fund was further supported with an additional USD 25.62 million in 2023, taking overall funding up to USD 57.64 million by 2027. Further, rising adoption of home-based fertility kits and advanced diagnostic technologies is driving market growth.
The U.S. Fertility Test Market Insights
The U.S. dominated the fertility test industry due to high infertility rates and strong awareness programs for reproductive health. Moreover, availability of advanced home and clinical fertility testing solutions encourages adoption. In addition, digital integration with fertility apps supports consumer engagement.
Europe Fertility Test Market Insights
Europe holds the substantial share in the fertility test market owing to high demand for clinical fertility tests and rising female workforce delaying childbirth. Additionally, well-established healthcare infrastructure supports adoption of advanced fertility diagnostics. In addition, growing preference for personalized reproductive health solutions drives regional growth.
Asia Pacific Fertility Test Market Insights
Asia Pacific is the fastest growing market driven by increasing infertility prevalence in urban populations and rising awareness regarding reproductive health. A study by the Indian Society of Assisted Reproduction found that about 10–14% of India’s population experiences infertility. Additionally, rapid growth of e-commerce channels and digital fertility-tracking solutions are enhancing market penetration. Furthermore, government initiatives complement reproductive health care access.
China Fertility Test Market Insights
China is expanding rapidly due to rising urban infertility treatment and evolving family planning patterns. Furthermore, government campaigns encouraging reproductive health knowledge increase test uptake. Besides, increasing e-commerce penetration makes broader distribution of home-based fertility kits possible.
Key Players & Competitive Analysis Report
The market for fertility tests is moderately competitive, with organizations improving home and clinical test solutions through AI-driven monitoring, digitalization, and enhanced hormone and ovulation detection technologies. Collaboration with fertility clinics, e-commerce sites, and healthcare operators also enhances market access, scalability, and consumer adoption worldwide.
Key players in the market for fertility tests are Church & Dwight Co., Inc., Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products, Prestige Brands Holdings Inc., Quidel Corporation, Babystart Ltd, UEBE Medical GmbH, Abbott Laboratories, and Laboratory Corporation of America Holdings.
Key Players
- Abbott Laboratories
- Babystart Ltd
- Church & Dwight Co., Inc.
- Fairhaven Health LLC
- Fertility Focus Limited
- Geratherm Medical AG
- HiLin Life Products
- Laboratory Corporation of America Holdings
- Prestige Brands Holdings Inc.
- Quidel Corporation
- Swiss Precision Diagnostics GmbH
- UEBE Medical GmbH
Industry Development
- October 2025: Genie Fertility raised USD 1.2 million to develop a non-invasive fertility test that uses menstrual blood to provide more accurate reproductive health insights.
- October 2025: Sapyen has launched the UK’s first at-home male fertility test kit, allowing men to collect samples at home and receive lab-verified results in days.
- August 2025: Maven Clinic has launched a cycle tracker and at-home male fertility tools to give people earlier, personalized guidance in trying to conceive.
Fertility Test Market Segmentation
By Product (Revenue, USD Billion, 2020–2034)
- Ovulation Prediction Kits
- Fertility Monitors
- Urine-Based Monitors
- Saliva-Based Monitors
- Other Fertility Monitors
- Male Fertility Testing Products
By Mode of Purchase (Revenue, USD Billion, 2020–2034)
- Direct/Prescription Products
- OTC Products
- Online Products
By Application (Revenue, USD Billion, 2020–2034)
- Female Fertility Testing
- Male Fertility Testing
By End User (Revenue, USD Billion, 2020–2034)
- Home Care Settings
- Hospitals and Fertility Centers
- Other End User
By Region (Revenue, USD Billion, 2020–2034)
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Latin America
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of South Africa
Fertility Test Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 7.14 Billion |
|
Market Size in 2025 |
USD 7.69 Billion |
|
Revenue Forecast by 2034 |
USD 15.22 Billion |
|
CAGR |
7.88% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2025-2034 |
|
Forecast Period |
2025-2034 |
|
Quantitative Units |
Revenue in USD Billion and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Application |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions and segmentation. |
FAQ's
The global market size was valued at USD 7.14 billion in 2024 and is projected to grow to USD 15.22 billion by 2034.
The global market is projected to register a CAGR of 7.88% during the forecast period.
North America dominated the fertility test market in 2024 due to rising infertility cases and strong awareness of reproductive health.
A few of the key players in the market are Church & Dwight Co., Inc., Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products, Prestige Brands Holdings Inc., Quidel Corporation, Babystart Ltd, UEBE Medical GmbH, Abbott Laboratories, and Laboratory Corporation of America Holdings.
Ovulation prediction kits dominated in 2024 owing to high adoption of home-based fertility monitoring solutions.
Hospitals and fertility centers are projected to grow fastest, driven by clinical-grade fertility testing demand and digital monitoring adoption.
© 2026 Polaris Market Research and Consulting. All rights reserved
